144 related articles for article (PubMed ID: 34817361)
1. Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy.
Cortés H; Reyes-Hernández OD; Gonzalez-Torres M; Vizcaino-Dorado PA; Del Prado-Audelo ML; Alcalá-Alcalá S; Sharifi-Rad J; Figueroa-González G; González-Del Carmen M; Florán BN; Leyva-Gómez G
Cell Mol Biol (Noisy-le-grand); 2021 Jan; 67(1):101-105. PubMed ID: 34817361
[TBL] [Abstract][Full Text] [Related]
2. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review.
Mandal M; Jaiswal P; Mishra A
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22478. PubMed ID: 32124518
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
Abbaoui A; Chatoui H; El Hiba O; Gamrani H
Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
[TBL] [Abstract][Full Text] [Related]
4. CNB-001 a novel curcumin derivative, guards dopamine neurons in MPTP model of Parkinson's disease.
Jayaraj RL; Elangovan N; Manigandan K; Singh S; Shukla S
Biomed Res Int; 2014; 2014():236182. PubMed ID: 25025041
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature.
Nebrisi EE
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681908
[TBL] [Abstract][Full Text] [Related]
7. Curcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness.
Phom L; Achumi B; Alone DP; Muralidhara ; Yenisetti SC
Rejuvenation Res; 2014 Dec; 17(6):481-9. PubMed ID: 25238331
[TBL] [Abstract][Full Text] [Related]
8. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Kundu P; Das M; Tripathy K; Sahoo SK
ACS Chem Neurosci; 2016 Dec; 7(12):1658-1670. PubMed ID: 27642670
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
Sarkar S; Raymick J; Imam S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
[TBL] [Abstract][Full Text] [Related]
10. Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease.
Ramires Júnior OV; Alves BDS; Barros PAB; Rodrigues JL; Ferreira SP; Monteiro LKS; Araújo GMS; Fernandes SS; Vaz GR; Dora CL; Hort MA
Neurotox Res; 2021 Jun; 39(3):787-799. PubMed ID: 33860897
[TBL] [Abstract][Full Text] [Related]
11. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
12. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies.
Jagatha B; Mythri RB; Vali S; Bharath MM
Free Radic Biol Med; 2008 Mar; 44(5):907-17. PubMed ID: 18166164
[TBL] [Abstract][Full Text] [Related]
13. Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson's disease.
Harish G; Venkateshappa C; Mythri RB; Dubey SK; Mishra K; Singh N; Vali S; Bharath MM
Bioorg Med Chem; 2010 Apr; 18(7):2631-8. PubMed ID: 20227282
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease.
Baul HS; Manikandan C; Sen D
Brain Res Bull; 2019 Mar; 146():244-252. PubMed ID: 30664919
[TBL] [Abstract][Full Text] [Related]
15. Curcumin: a potential neuroprotective agent in Parkinson's disease.
Mythri RB; Bharath MM
Curr Pharm Des; 2012; 18(1):91-9. PubMed ID: 22211691
[TBL] [Abstract][Full Text] [Related]
16. Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy.
Zhang N; Yan F; Liang X; Wu M; Shen Y; Chen M; Xu Y; Zou G; Jiang P; Tang C; Zheng H; Dai Z
Theranostics; 2018; 8(8):2264-2277. PubMed ID: 29721078
[No Abstract] [Full Text] [Related]
17. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease.
Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS
J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
Wang MS; Boddapati S; Emadi S; Sierks MR
BMC Neurosci; 2010 Apr; 11():57. PubMed ID: 20433710
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity.
Bollimpelli VS; Kumar P; Kumari S; Kondapi AK
Neurochem Int; 2016 May; 95():37-45. PubMed ID: 26826319
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
